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The choroid plexus is a multifunc-tional organ that sits at the
interface between the blood and cere-
brospinal fluid (CSF). It serves as a
gateway for immune cell trafficking into
the CSF and is in an excellent position to
provide continuous immune surveillance
by CD4+ T cells, macrophages and
dendritic cells and to regulate immune
cell trafficking in response to disease and
trauma. However, little is known about
the mechanisms that control trafficking
through this structure. Three cell types
within the choroid plexus, in particular,
may play prominent roles in controlling
the development of immune responses
within the nervous system: the epithelial
cells, which form the blood-CSF
barrier, and resident macrophages and
dendritic cells in the stromal matrix.
Adhesion molecule and chemokine
expression by the epithelial cells allows
substantial control over the selection of
cells that transmigrate. Macrophages
and dendritic cells can present antigen
within the choroid plexus and/or trans-
migrate into the cerebral ventricles to
serve a variety of possible immune
functions. Studies to better understand
the diverse functions of these cells are
likely to reveal new insights that foster
the development of novel pharmaco-
logical and macrophage-based interven-
tions for the control of CNS immune
responses.
Once considered isolated from the
immune system, it is now clear that the
central nervous system (CNS) is continu-
ously monitored by immune cells, many of
which circulate through the cerebrospinal
fluid (CSF). On average, normal CSF
contains about 1.12 white blood cells/ml1
with approximately 500,000 immune cells
trafficking through the ventricles each day.
Within the CNS, specialized tissue inter-
faces and intrinsic factors play a prominent
role in the control of this trafficking and
the development of inflammatory
responses. These interfaces include the
blood-brain barrier, the choroid plexus
and the meningeal vasculature. While
considerable attention has been paid to
immune cell interactions at the blood-
brain barrier, fewer studies have focused
on the role of the blood-cerebrospinal fluid
barrier within the choroid plexus and
meninges.2-4 The limited knowledge of
the control of immune cell trafficking at
the blood-CSF barrier stands in stark
contrast to the widespread use of CSF
leukocyte pleocytosis in clinical studies to
evaluate inflammation in the CNS.
Available evidence clearly indicates that
the choroid plexus has many unique
features such as abundant dendritic cells,5
macrophages6 and patterns of epithelial
adhesion molecule expression7 that sup-
port continuous immunosurveillance1,8,9 as
well as the ability to regulate cell activation
and trafficking in response to pathological
insults.8,10 However, many outstanding
questions remain regarding the regulation
and function of immune cell trafficking
through the choroid plexus into the
cerebral ventricles. How are these cells
recruited? What regulates the extent and
selectivity of the trafficking? How do the
immune cells function after entry into
the CSF? In this commentary we discuss
the dynamic role of the choroid plexus
in the control of CNS immune cell
trafficking.
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The Choroid Plexus and Meningeal
Vasculature as a Gateway
to the CNS
The choroid plexus is a specialized organ
with unique properties, the best known of
which is the production of CSF. It extends
from the ependyma of the lateral, third and
fourth ventricles of the brain and is
composed of blood vessels surrounded by
a stromal matrix and a single layer of
cuboidal epithelium (Fig. 1).2 CSF is
produced by the cuboidal epithelium at a
high rate of 0.2–0.4 ml/min/g of tissue in
mammals with a turnover of 3–4 times/
day.11-13 To support this production of
CSF, the choroid plexus maintains a rate of
blood flow that is ~5–10 times greater than
other tissues. This high rate of blood flow
and the absence of a vascular barrier
(fenestrated capillaries with no tight junc-
tions) also provide excellent exposure to
circulating immune cells within the choroid
plexus. Cells that transmigrate across the
endothelium enter a stromal matrix that
contains numerous macrophages and dend-
ritic cells poised for interactions. To gain
access to the CSF, cells must then traverse
the cuboidal epithelium, which expresses
tight junctions that form the blood-CSF
barrier. While the epithelium serves many
functions that have been the focus of
excellent reviews,11,14 this commentary will
discuss the role of the choroid plexus in the
regulation of immune cell trafficking.
Adhesion Molecule Expression
in the Choroid Plexus
Early studies of the choroid plexus began to
reveal its potential immunological import-
ance by demonstrating the expression of
adhesion molecules on the surface of the
choroid plexus epithelium and the ability
of the epithelial cells to present antigen to
T cells.15 Anatomical studies described
macrophages on the surface of the ven-
tricles (epiplexus cells) suggesting that these
cells may traffic into the CSF from the
choroid plexus.16 Support for this view was
obtained from experiments showing that
systemically delivered markers that do not
cross the blood-brain or blood-CSF barriers
did appear in ventricular macrophages.17
Highly efficient communication between
the CSF and the immune system was
shown by studies demonstrating a potent
immune response after delivery of antigens
directly into the CSF18 and the devel-
opment of unusually high systemic viral
titers after infusion of immunodeficiency
virus into the CSF.19 Numerous studies
have subsequently illustrated that the
choroid plexus and meninges are uniquely
structured to support and regulate immune
cell trafficking.
Adhesion molecules are expressed on
the epithelium. An important feature of the
choroid plexus is the expression of the
adhesion molecules VCAM-1, ICAM-1,
P-selectin and E-cadherin on the epithe-
lium rather than the vascular endothe-
lium.7,20-24 This suggests that trafficking
within the choroid plexus is largely con-
trolled by the epithelium. These adhesion
molecules are also expressed along venules
at the base of the choroid plexus and within
the meninges.7,25 Importantly, ICAM-1,
VCAM-1 and P-selectin are constitutively
expressed at these sites suggesting an
environment that supports continuous traf-
ficking of immune cells and immunosur-
veillance of the nervous system.9,10 Other
adhesion molecules such as MadCAM are
Figure 1. Left: schematic representation of the choroid plexus showing the multi-lobed structure that extends from the ependyma into the lateral, third
and fourth ventricles. The choroidal artery and arterioles entering through the stalk provide a rich supply of blood that circulates through the choroid
plexus and then exits via venules. Right: a small segment of epithelium adjacent to a single capillary is depicted. The vascular endothelium is separated
from the epithelium by a stromal matrix that contains numerous macrophages and dendritic cells. Trafficking cells easily transmigrate across the
fenestrated vascular endothelium, which has no barrier. To reach the cerebrospinal fluid (CSF) in the cerebral ventricles, migrating cells must traverse the
stroma and the epithelium, which contains tight junctions that form the blood-CSF barrier. The resident macrophages and dendritic cells in the stroma
may also transmigrate across the epithelium into the CSF.
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expressed de novo in response to specific
stimuli such as infections.26 VCAM-1,
ICAM-1 and MadCAM are all upregulated
in the choroid plexus epithelium in response
to autoimmune responses,23 infection23,27
and traumatic brain injury.28 Similar upre-
gulation could be seen in vitro after
exposing choroid plexus epithelial cells to
proinflammatory molecules, illustrating
their direct responsiveness to inflammatory
stimuli.12 Regulation also occurs at the
stromal venules exiting the choroid plexus,
which express P-selectin, E-selectin and
ICAM-1 and support leukocyte traffick-
ing.7,25 While it is clear from these studies
that choroidal epithelium and the associated
vasculature support immune cell trafficking,
detailed studies of adhesion molecule
expression under different conditions are
needed to better appreciate the extent of
control at these sites.
Immune Cell Trafficking
through the Choroid Plexus
Immune cell trafficking into the CSF
under normal conditions. Up to 450,000
white blood cells are normally found
within the CSF of healthy adults (0–3
cells/mm3) with a CSF:blood ratio of
~1:2,500 for lymphocytes and 1:2,000
for monocytes.1,7 The composition of
these cells is quite different from blood
indicating that the cells are highly selected
for entry into the brain compartment.
Flow cytometry studies designed to define
the leukocyte populations in normal CSF
have only recently been performed.
Patients undergoing surgery for non-
neurological conditions had an average of
1.12 leukocytes/ml in CSF with the
following relative composition: 8% gran-
ulocytes, 68% lymphocytes, 23% mono-
cytes and 2.2% myeloid dendritic cells.1 In
contrast to normal blood (58.5% granu-
locytes, 35% lymphocytes 6.5% mono-
cytes and 0.24% dendritic cells), the
relative composition of cells in the CSF
was heavily weighted toward dendritic cells
(2.2% vs. 0.24%) and monocytes (23%
vs. 6.5%). T cells, the most abundant cells
in CSF, were enriched moderately relative
to blood (68% vs 35%). Notably, most T
cells were CD4+ central memory
(CD45RA2/CD27/28+) T cells with
retention of capacity for homing to
secondary lymphoid organs.25 Forty-six
percent of these T cells were also CD69+
vs. 4% in blood indicating recent activa-
tion.1,25 Like the CD4+ T cells, CD8+ T
cells that penetrated into the CSF were
mostly activated central memory cells.
Natural killer (NK) cells and B cells were
very low in normal CSF suggesting that
they are not involved in normal immune
surveillance of the central nervous system.
The functions of the T cells and mono-
cytic cells that routinely circulate in the
CSF are not well understood but may
involve different functional pathways.
Expression of adhesion molecules
VCAM-1 and ICAM-1 on the luminal
side of the choroid plexus epithelium7
suggests that immune cells in the CSF
might traffic back into the choroid plexus
where they could interact with resident
macrophages/dendritic cells and/or re-
enter the blood stream. Alternatively,
immune cells could follow the flow of
the CSF and exit the CNS compartment
into cervical lymph nodes or blood and
ultimately contribute to a more general
immune response. In each case, macro-
phages and dendritic cells are in an
Figure 2. (A) Iba1 immunoreactive monocytic cells (arrows) within the stroma of the choroid plexus of a cat infected with feline immunodeficiency virus.
(B) Macrophages/dendritic cells labeled with DiI acetylated low density lipoprotein (LDL) in the stalk of a choroid plexus explant imaged at low
magnification. Regions with abundant macrophages tend to follow the vasculature within the stalk. (C) Initially absent on the surface of the choroid
plexus, large numbers of DiI acetylated LDL labeled cells (arrows) migrate to the surface of the epithelium of a choroid plexus explant cultured in vitro.
The epithelium in the background is stained with the live cell stain calcein. Inset: Enlarged view of a single labeled macrophage/dendritic cell
(arrowhead) with a process extending between epithelial cells.
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excellent position to initiate an early innate
immune response that primes the nervous
system through the secretion of cytokines
(inflammatory and anti-inflammatory),
chemokines and/or growth factors.
A unique feature of the choroid plexus
is the presence of a large population of
macrophages and dendritic cells within the
stroma (Fig. 2A) and adjacent to blood
vessels within the base of the choroid
plexus (Fig. 2B). In rat choroid plexus,
MHC II+/OX62+ dendritic cells outnum-
bered CD68+/ED2+ resident tissue macro-
phages in the stroma with the opposite
pattern in the pial leptomeninges.29 In
patients with multiple sclerosis (MS), viral
encephalitis and HIV infection, intense
HLA-DR staining was seen in the choroid
plexus stroma, epithelium and epiplexus
cells indicating active participation in
antigen presentation.5,24 In studies
designed to explore the early response to
lentiviral infection, lymphocyte trafficking
into the choroid plexus was one of the
earliest signs of pathology reinforcing the
view that this structure may serve as an
early warning system to set the stage for
subsequent immune interactions.30
The choroid plexus may provide a rich
source of macrophages and dendritic cells
that traffic into the cerebral ventricles. The
extent of macrophage and dendritic cell
trafficking from the choroid plexus into the
cerebral ventricles may be more robust than
generally appreciated. In choroid plexus
explants cultured in vitro we have shown
that macrophages/dendritic cells labeled
with DiI-acetylated low density lipoprotein
(LDL) increased in number and migrated
to the apical surface of the epithelium8
(Fig. 2C). The rapid expansion of these
cells and the migration was highly depend-
ent on the presence of epithelial cells and
was not dependent on an experimental
chemokine gradient. The direction of
migration was preferentially through the
epithelial barrier even when little or no
barrier was present in the opposite dir-
ection, suggesting that the cells are drawn to
the epithelium. The migration in the
absence of an external challenge was
substantial and the expansion and migra-
tion of these cells was further enhanced in
the presence of immunodeficiency virus.8
This response indicted that robust mechan-
isms are present in the isolated organ that
recruit macrophages across the epithelium
under both normal and pathological con-
ditions. The functions of these cells in the
CSF are not known. However, in prelim-
inary unpublished studies, the potential
potency of trafficking macrophages was
demonstrated by the induction of intense
and widespread neutrophil trafficking into
the brain after infusion of 105 lentivirus-
infected choroid plexus-derived macro-
phages into the lateral ventricle (approxi-
mately 50 cells/ml of CSF). Cultured
PBMCs or free virus failed to produce a
similar response. How these cells induced
such a potent and widespread response is
not known. These observations raise
numerous possibilities for the functions of
these macrophages as well as the potential
for therapeutic manipulation. For example,
monocyte/macrophages are currently being
engineered for the delivery of antiretroviral
and other drugs to sites within the CNS.31
Natural targeting of these cells to damaged
regions guided by secreted chemokines
would be expected to provide selective
and efficient delivery of therapeutic agents.
Based on our observations, we believe that
macrophages trafficking into the CSF from
the choroid plexus and associated vascula-
ture play a critical role in the evolution of
CNS immune responses. A better under-
standing of the functions of the choroid
plexus macrophages may reveal novel
opportunities for control of CNS inflam-
mation, neural repair and neurogenesis.
Much needs to be done to explore this
possibility as many important questions
remain to be answered: What is the extent
of their influence on recruitment and
trafficking of other immune cells? How
robust is macrophage trafficking into the
ventricles in vivo? What is the functional
Figure 3. Leukocyte populations in human CSF under normal and pathological conditions.
The relative abundance of cells (percentage of total cells) in CSF from patients was summarized
from de Graaf et al.,1 Kivisäkk et al.,25 Neuenberg et al.35 and Provencio et al.9 The predominant cells
in normal CSF were T cells (49% CD4+, 19% CD8+). Monocytes were the second most abundant
leukocyte found in normal CSF (23%) while B cells, granulocytes and dendritic cells were present at
low levels. The percentage composition may change in response to various diseases as illustrated
(MS, multiple sclerosis; NB, neuroborreliosis; BM, bacterial meningitis; VM, viral meningitis). B cells
were increased compared with normal CSF during infections such as NB (14.2% vs. , 1%) and
during MS (3.9% vs. , 1%). Because of large increases in lymphocytes and granulocytes in some
diseases, monocytes may increase in number but constitute a lower percentage of the total CSF cell
population. For example, monocyte numbers increase approximately 500-fold in BM relative to
normal CSF but represent only about 3.8% of total CSF cells.
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impact of antigen presentation within the
choroid plexus? Do ventricular macro-
phages enter the brain parenchyma or
simply exit the nervous system into blood
and lymph nodes?
Immune cell trafficking into the CSF
varies greatly in response to disease and
trauma. A study of CSF cell populations in
65 patients with various inflammatory
diseases of the CNS (MS, neuroborreliosis,
bacterial infection, viral infection and
malignancies) identified patterns unique to
each disease.10,28 The normal cellular com-
position of CSF and changes in major cell
subsets seen in response to various diseases
are summarized in Figure 3. These changes
may reflect trafficking of immune cells
through the blood-brain barrier and men-
ingeal vasculature as well as the choroid
plexus although the relative contribution
from various sources is still poorly under-
stood. Neuroborreliosis (NB) was associated
with increased numbers of activated lym-
phocytes and CD192/CD138+ plasma cells
in the CSF; viral encephalitis/meningitis
(VM) with activated CD4+ lymphocytes
and neutrophils; bacterial meningitis (BM)
and traumatic brain injury with monocytes
and neutrophils, MS with activated CD4+
and CD8+ lymphocytes and plasma cells
and malignancies with malignant cells and
activated monocytes. In each case, the cells
that traffic into the CSF do not reflect the
composition of immune cells in
blood.10,28,32 Cells within the CSF may also
vary over time. For example, the early stages
of viral encephalitis and meningitis present
with neutrophil infiltration and are followed
at later stages by mostly CD3+/CD4+
lymphocytes.10 The unique trafficking pat-
terns led Adam et al.10 to suggest that the
cellular composition of CSF may have
diagnostic potential. In addition, the traf-
ficking patterns may provide insights into
the various ways in which the choroid
plexus selects and activates immune cells.
What stimulates the trafficking of
immune cells through the choroid plexus?
Many studies have examined chemokines
within the CSF to begin to explain
trafficking and in many cases correlations
exist between specific chemokines and CSF
immune cells that express the appropriate
chemokine receptor. However, some have
pointed out the substantial epithelial and
stromal barriers that would prevent
circulating or newly migrated immune cells
from sensing CSF chemokines. How then
do cells find their way through these
barriers? Studies of neutrophil trafficking
have shown that the epithelium may release
chemokines in a polarized fashion to attract
cells to their surface and facilitate trans-
migration.33 These observations again point
to the epithelium as a critical element in
the regulation of immune cell trafficking.
Table 1 illustrates the chemokine profile in
“normal” CSF from patients with no
significant inflammation or detectable neu-
rodegenerative disease (adapted from
Meeker et al.34). The CSF profile is
dominated by chemokines that attract
monocytes, such as CCL-2 (MCP-1),
IL-8, fractalkine, MIP-1β, MIP-1d and
MIP-3a. This would be consistent with
the in vitro studies described above showing
robust movement of macrophages through
the epithelium where they could then
respond to chemokines circulating in the
CSF. The chemokine profile is also consist-
ent with the preferential accumulation of
monocytic cells in human CSF as described
above. The fate of these cells is unclear.
Some may become epiplexus cells residing
on the on the wall of the ventricles where
they would not easily be detected. Many
may also have a dendritic phenotype not
visible with standard monocyte markers.
More detailed studies focusing on macro-
phage and dendritic cell phenotypes and
functions may provide a better appreciation
of the number and fate of cells entering the
CSF from the choroid plexus.
The chemokine profiles in CSF can
change substantially in response to disease
and trauma but the origin of these changes
is also poorly understood. CCL2 increases
and decreased during different stages of
MS and perhaps HIV infection. CXCL10
increases in both MS and HIV infection.
Macrophages/dendritic cells, epithelium
and parenchymal cells may all contribute
to the secretion of these and other
chemokines into the CSF but the con-
tributions of each are not well understood.
This is a relatively unexplored area that
Table 1. Chemokines in normal human CSF
Chemokine Common name Receptor Relative expression (%) ± sem
CCL2 MCP-1 CCR2 18.022 ± 1.710
CXCL8 IL-8 CXCR1, CXCR2 1.040 ± 0.477
CX3CL1 Fractalkine CX3CR1 0.915 ± 0.204
CCL18 PARC, MIP-4 - 0.841 ± 0.235
CCL4 MIP-1b CCR5 0.758 ± 0.435
CCL15 MIP-1d CCR1, CCR3 0.730 ± 0.151
CCL22 MDC CCR4 0.674 ± 0.160
CCL20 MIP-3a CCR6 0.626 ± 0.144
XCL1 Lymphotactin XCR1 0.483 ± 0.069
CCL18 I-309 CCR8 0.453 ± 0.065
CCL24 Eotaxin-3 CCR3 0.426 ± 0.233
CCL3 MIP-1a CCR5, CCR1 0.412 ± 0.252
CCL25 TECK CCR9 0.305 ± 0.068
CXCL11 I-TAC CXCR3 0.243 ± 0.051
CCL19 MIP-3b CCR7 0.203 ± 0.063
CXCL12 SDF-1 CXCR4 0.154 ± 0.080
CCL5 RANTES CCR1, CCR3, CCR5 ND
CCL17 TARC CCR4, CCR8 ND
CXCL13 BCA-1 CXCR5 N/A
CXCL10 IP-10 CXCR3 N/A
Relative expression of chemokines in CSF was calculated as the % of total protein content on an array
of 120 proteins (Ray BioTech). Values below 0.45 were generally not considered to be significantly
greater than zero using a p value of 0.01. ND, no detectable signal; N/A, known to be present in CSF
but not available on the array.
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needs greater attention to provide a better
understanding of how different cells
coordinate with the choroid plexus to
control immune cell trafficking.
Summary
In contrast to the blood-brain barrier, the
choroid plexus is structured to interact
more dynamically with the immune
system including mechanisms to support
continuous immunosurveillance and spe-
cific responses to disease and injury.
Epithelium and a large population of
macrophages/dendritic cells appear to be
major players in these responses via their
capacity for adhesion molecule expression,
chemokine secretion, antigen presentation
and active surveillance. However, more
work needs to be done to better appreciate
the influence of the choroid plexus on the
development of CNS immune responses.
Insights into these mechanisms may
provide opportunities to develop thera-
peutic interventions that control inflam-
mation and repair processes in the CNS.
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